BACKGROUND: Treatments now available for mucopo-lysaccharidosis I require early detection for optimum therapy. Therefore, we have developed an assay appro-priate for newborn screening of the activity of the rel-evant enzyme, -L-iduronidase. METHODS: We synthesized a new -L-iduronidase sub-strate that can be used to assay the enzyme by use of tandem mass spectrometry together with an internal standard. The assay uses a dried blood spot on a new-born screening card as the enzyme source. The assay protocol uses a simple liquid-liquid extraction step be-fore mass spectrometry. We optimized enzyme reac-tion conditions and procedures for the assay, including the concentration of substrate, the reaction pH, the incubation time, andmass spectromete...
disease,Niemann-Pick disease typesA andB, andKrabbe disease have engendered interest in the use of t...
We report new substrates for quantitative enzyme activity measurements of human palmitoyl protein th...
Background: With ongoing efforts to develop improved treatments for Sanfilippo Syndrome Type A (MPS-...
washington.edu) Background: A treatment for mucopolysaccharidosis II (Hunter syndrome) has recently ...
ABSTRACT: Tandem mass spectrometry for the multiplex and quantitative analysis of enzyme activities ...
Tandem mass spectrometry for the multiplex and quantitative analysis of enzyme activities in dried b...
lysosomal enzymes that cause Fabry, Gaucher, Krabbe, Niemann–Pick A/B, and Pompe diseases is warrant...
AbstractIn this data article we provide a detailed standard operating procedure for performing a tan...
In this data article we provide a detailed standard operating procedure for performing a tandem mass...
All worldwide newborn screening (NBS) for lysosomal storage diseases (LSDs) is performed as a first-...
OBJECTIVES: High-throughput mass spectrometry methods have been developed to screen newborns for lys...
ABSTRACT: We report new substrates for quantitative enzyme activity measurements of human palmitoyl ...
A new tandem mass spectrometry (MS/MS)-based approach for measurement of the enzymatic activity of p...
Mucopolysaccharidosis type I (MPS I) was added to our expanded screening panel in 2015. Since then, ...
Abstract Background: Interest in screening methods for lysosomal storage diseases (LSDs) has increa...
disease,Niemann-Pick disease typesA andB, andKrabbe disease have engendered interest in the use of t...
We report new substrates for quantitative enzyme activity measurements of human palmitoyl protein th...
Background: With ongoing efforts to develop improved treatments for Sanfilippo Syndrome Type A (MPS-...
washington.edu) Background: A treatment for mucopolysaccharidosis II (Hunter syndrome) has recently ...
ABSTRACT: Tandem mass spectrometry for the multiplex and quantitative analysis of enzyme activities ...
Tandem mass spectrometry for the multiplex and quantitative analysis of enzyme activities in dried b...
lysosomal enzymes that cause Fabry, Gaucher, Krabbe, Niemann–Pick A/B, and Pompe diseases is warrant...
AbstractIn this data article we provide a detailed standard operating procedure for performing a tan...
In this data article we provide a detailed standard operating procedure for performing a tandem mass...
All worldwide newborn screening (NBS) for lysosomal storage diseases (LSDs) is performed as a first-...
OBJECTIVES: High-throughput mass spectrometry methods have been developed to screen newborns for lys...
ABSTRACT: We report new substrates for quantitative enzyme activity measurements of human palmitoyl ...
A new tandem mass spectrometry (MS/MS)-based approach for measurement of the enzymatic activity of p...
Mucopolysaccharidosis type I (MPS I) was added to our expanded screening panel in 2015. Since then, ...
Abstract Background: Interest in screening methods for lysosomal storage diseases (LSDs) has increa...
disease,Niemann-Pick disease typesA andB, andKrabbe disease have engendered interest in the use of t...
We report new substrates for quantitative enzyme activity measurements of human palmitoyl protein th...
Background: With ongoing efforts to develop improved treatments for Sanfilippo Syndrome Type A (MPS-...